These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 22883471)
1. Marked eosinophilia in a patient with history of severe atypical Kawasaki disease. O'Byrne ML; Cohen MS Congenit Heart Dis; 2013; 8(5):E130-3. PubMed ID: 22883471 [TBL] [Abstract][Full Text] [Related]
2. Both patient characteristics and IVIG product-specific mechanisms may affect eosinophils in immunoglobulin-treated Kawasaki disease. Khan S; Doré PC; Sewell WA Pediatr Allergy Immunol; 2008 Mar; 19(2):186-7. PubMed ID: 18257907 [No Abstract] [Full Text] [Related]
3. Drug-induced hypersensitivity syndrome: drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome induced by aspirin treatment of Kawasaki disease. Kawakami T; Fujita A; Takeuchi S; Muto S; Soma Y J Am Acad Dermatol; 2009 Jan; 60(1):146-9. PubMed ID: 19103366 [TBL] [Abstract][Full Text] [Related]
4. Patient characteristics and intravenous immunoglobulin product may affect eosinophils in Kawasaki disease. Kuo HC; Wang CL; Wang L; Yu HR; Yang KD Pediatr Allergy Immunol; 2008 Mar; 19(2):184-5. PubMed ID: 18257906 [No Abstract] [Full Text] [Related]
5. Intestinal ischaemia as a severe presentation of Kawasaki disease leading to short-bowel syndrome. Godart F; Bakhti OM; Bonnevalle M Cardiol Young; 2014 Jun; 24(3):567-70. PubMed ID: 23962748 [TBL] [Abstract][Full Text] [Related]
6. Hair loss as a sign of Kawasaki disease. Nabavizadeh SH; Safari M; Amin R Iran J Allergy Asthma Immunol; 2006 Dec; 5(4):199-200. PubMed ID: 17237574 [TBL] [Abstract][Full Text] [Related]
7. An observational study on peripheral blood eosinophilia in incomplete Kawasaki disease. Öner T; Yılmazer MM; Güven B; Devrim I; Cilengiroğlu ÖV; Demirpençe S; Meşe T; Tavlı V; Vitrinel A Anadolu Kardiyol Derg; 2012 Mar; 12(2):160-4. PubMed ID: 22306569 [TBL] [Abstract][Full Text] [Related]
8. The relationship of eosinophilia to intravenous immunoglobulin treatment failure in Kawasaki disease. Kuo HC; Yang KD; Liang CD; Bong CN; Yu HR; Wang L; Wang CL Pediatr Allergy Immunol; 2007 Jun; 18(4):354-9. PubMed ID: 17584314 [TBL] [Abstract][Full Text] [Related]
9. Kawasaki disease and alopecia areata: coincidence or a true association? Krishnamurthy S; Chandrashekar L; Mondal N Pediatr Dermatol; 2012; 29(4):532-4. PubMed ID: 21906152 [TBL] [Abstract][Full Text] [Related]
10. The role of bacterial lipopolysaccharide-bound neutrophils in the pathogenesis of Kawasaki disease. Takeshita S; Nakatani K; Kawase H; Seki S; Yamamoto M; Sekine I; Yoshioka S J Infect Dis; 1999 Feb; 179(2):508-12. PubMed ID: 9878040 [TBL] [Abstract][Full Text] [Related]
12. Clinical features of atypical Kawasaki disease. Hsieh YC; Wu MH; Wang JK; Lee PI; Lee CY; Huang LM J Microbiol Immunol Infect; 2002 Mar; 35(1):57-60. PubMed ID: 11950122 [TBL] [Abstract][Full Text] [Related]
13. A patient with kawasaki disease showing severe tricuspid regurgitation and left ventricular dysfunction in the acute phase. Shinohara T; Tanihira Y Pediatr Cardiol; 2003; 24(1):60-3. PubMed ID: 12574980 [TBL] [Abstract][Full Text] [Related]